Imperial College Healthcare NHS TrustLondon, United Kingdom
Disclosure information not submitted.
ORF49-03 - Thyroid Eye Disease Following Immunomodulatory Therapy for Multiple Sclerosis: A Case Series
Monday, June 15, 20261:55 PM - 2:00 PM CT